4 stories mentioning BOM:533229Updated 16d ago
Every FINWIRES story that references BOM:533229, newest first.
Bajaj Consumer Care (BOM:533229, NSE:BAJAJCON) has an average rating of buy and mean price target of 574.25 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Bajaj Consumer Care (BOM:533229, NSE:BAJAJCON) has an average rating of buy and mean price target of 564.25 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Indian benchmark indices ended higher on Friday as broad-based buying lifted markets, supported by gains in consumer goods and oil & gas stocks.The BSE Sensex rose 504.86 points, or 0.7%, to close at 78,493.54, while the NSE Nifty 50 gained 156.80 points, or also 0.7%, to settle at 24,353.55.Sentiment improved on expectations of easing tensions in the Middle East. Reports of a possible progress in U.S.-Iran negotiations and a potential extension of the ceasefire supported risk appetite.A sharp decline in crude oil prices further supported the market.In corporate developments, Bajaj Consumer Care (NSE:BAJAJCON, BOM:533229) reported a rise in consolidated profit to 636.0 million rupees in the fiscal fourth quarter from 309.8 million rupees a year earlier.Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) received U.S. FDA approval to manufacture and market Glycerol Phenylbutyrate Oral Liquid. The product is equivalent to the reference drug Ravicti and will be launched immediately, the company said in a Friday filing.
Bajaj Consumer Care's (NSE:BAJAJCON, BOM:533229) consolidated profit jumped to 636.0 million Indian rupees in the fiscal fourth quarter ended March 31, from 309.8 million rupees a year ago.Earnings per share grew to 4.75 rupees from 2.23 rupees a year earlier, the personal care products manufacturer said in a filing to the Indian stock exchanges on Friday.Revenue from operations in fiscal Q4 also increased to 3.27 billion rupees from 2.50 billion rupees a year ago.The company's shares surged over 13% in recent trade.
